Allianz Asset Management
KURA icon

Allianz Asset Management’s Kura Oncology KURA Stock Holding History

Allianz Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,500
Closed -$205K – 2280
2024
Q3 		$205K Hold
10,500
– – ﹤0.01% 2083
2024
Q2 		$216K Buy
+10,500
New +$216K ﹤0.01% 2019
2020
Q2 		– Sell
-52,493
Closed -$522K – 2468
2020
Q1 		$522K Buy
52,493
+298
+0.6% +$3.41K ﹤0.01% 2041
2019
Q4 		$718K Buy
52,195
+293
+0.6% +$4.34K ﹤0.01% 2313
2019
Q3 		$787K Sell
51,902
-75,632
-59% -$1.35M ﹤0.01% 2213
2019
Q2 		$2.51M Buy
127,534
+35,600
+39% +$591K ﹤0.01% 1799
2019
Q1 		$1.52M Buy
91,934
+361
+0.4% +$5.56K ﹤0.01% 1937
2018
Q4 		$1.29M Sell
91,573
-3,336
-4% -$44.2K ﹤0.01% 1924
2018
Q3 		$1.66M Buy
+94,909
New +$1.82M ﹤0.01% 2021

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management's KURA Position: Q4 2024 in Review

Allianz Asset Management sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 10,500 shares — an estimated $205K sold.

Allianz Asset Management first reported a position in KURA in Q3 2018 and held it in 9 quarters. The position peaked at $2.51M in Q2 2019. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • Allianz Asset Management reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • Allianz Asset Management sold 10,500 Kura Oncology shares in Q4 2024, an estimated $205K.
  • Allianz Asset Management first reported a position in Kura Oncology in Q3 2018 and held it in 9 quarters.
  • Allianz Asset Management's Kura Oncology position peaked at $2.51M in Q2 2019.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on Allianz Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.